Filing Details
- Accession Number:
- 0001127602-14-024309
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-07-31 17:49:10
- Reporting Period:
- 2014-07-30
- Filing Date:
- 2014-07-31
- Accepted Time:
- 2014-07-31 16:49:10
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
816956 | Conmed Corp | CNMD | Electromedical & Electrotherapeutic Apparatus (3845) | 160977505 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1222114 | J Joseph Corasanti | 101 Winship Road New Hartford NY 13413 | Former President & Ceo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-07-30 | 5,000 | $0.00 | 137,685 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-07-30 | 2,534 | $39.38 | 135,151 | No | 4 | F | Direct | |
Common Stock | Acquisiton | 2014-07-30 | 10,000 | $0.00 | 145,151 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-07-30 | 5,067 | $39.38 | 140,084 | No | 4 | F | Direct | |
Common Stock | Acquisiton | 2014-07-30 | 15,000 | $0.00 | 155,084 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-07-30 | 7,601 | $39.38 | 147,483 | No | 4 | F | Direct | |
Common Stock | Acquisiton | 2014-07-30 | 20,000 | $0.00 | 167,483 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-07-30 | 10,134 | $39.38 | 157,349 | No | 4 | F | Direct | |
Common Stock | Acquisiton | 2014-07-30 | 16,250 | $0.00 | 173,599 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-07-30 | 8,234 | $39.38 | 165,365 | No | 4 | F | Direct | |
Common Stock | Acquisiton | 2014-07-30 | 62,500 | $19.93 | 227,865 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-07-30 | 47,273 | $39.38 | 180,592 | No | 4 | F | Direct | |
Common Stock | Acquisiton | 2014-07-30 | 62,500 | $29.92 | 243,092 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-07-30 | 55,095 | $39.38 | 187,997 | No | 4 | F | Direct | |
Common Stock | Acquisiton | 2014-07-30 | 62,500 | $26.69 | 250,497 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-07-30 | 52,566 | $39.38 | 197,931 | No | 4 | F | Direct | |
Common Stock | Acquisiton | 2014-07-30 | 62,500 | $16.46 | 260,431 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-07-30 | 44,556 | $39.38 | 215,875 | No | 4 | F | Direct | |
Common Stock | Acquisiton | 2014-07-30 | 40,000 | $21.19 | 255,875 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-07-30 | 30,886 | $39.38 | 224,989 | No | 4 | F | Direct | |
Common Stock | Acquisiton | 2014-07-30 | 62,500 | $19.26 | 287,489 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-07-30 | 46,749 | $39.38 | 240,740 | No | 4 | F | Direct | |
Common Stock | Acquisiton | 2014-07-30 | 62,500 | $27.63 | 303,240 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-07-30 | 53,302 | $39.38 | 249,938 | No | 4 | F | Direct | |
Common Stock | Acquisiton | 2014-07-30 | 62,500 | $26.09 | 312,438 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-07-30 | 52,096 | $39.38 | 260,342 | No | 4 | F | Direct | |
Common Stock | Acquisiton | 2014-07-30 | 62,500 | $32.93 | 322,842 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-07-30 | 57,451 | $39.38 | 265,391 | No | 4 | F | Direct | |
Common Stock | Disposition | 2014-07-30 | 109,035 | $39.25 | 156,356 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | F | Direct | |
No | 4 | M | Direct | |
No | 4 | F | Direct | |
No | 4 | M | Direct | |
No | 4 | F | Direct | |
No | 4 | M | Direct | |
No | 4 | F | Direct | |
No | 4 | M | Direct | |
No | 4 | F | Direct | |
No | 4 | M | Direct | |
No | 4 | F | Direct | |
No | 4 | M | Direct | |
No | 4 | F | Direct | |
No | 4 | M | Direct | |
No | 4 | F | Direct | |
No | 4 | M | Direct | |
No | 4 | F | Direct | |
No | 4 | M | Direct | |
No | 4 | F | Direct | |
No | 4 | M | Direct | |
No | 4 | F | Direct | |
No | 4 | M | Direct | |
No | 4 | F | Direct | |
No | 4 | M | Direct | |
No | 4 | F | Direct | |
No | 4 | M | Direct | |
No | 4 | F | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Rsus (restricted Stock Units) | Disposition | 2014-07-30 | 5,000 | $0.00 | 5,000 | $0.00 |
Common Stock | Rsus (restricted Stock Units) | Disposition | 2014-07-30 | 10,000 | $0.00 | 10,000 | $0.00 |
Common Stock | Rsus (restricted Stock Units) | Disposition | 2014-07-30 | 15,000 | $0.00 | 15,000 | $0.00 |
Common Stock | Rsus (restricted Stock Units) | Disposition | 2014-07-30 | 20,000 | $0.00 | 20,000 | $0.00 |
Common Stock | Rsus (restricted Stock Units) | Disposition | 2014-07-30 | 16,250 | $0.00 | 16,250 | $0.00 |
Common Stock | Sars (Stock Appreciation Rights) | Disposition | 2014-07-30 | 62,500 | $0.00 | 62,500 | $19.93 |
Common Stock | Sars (Stock Appreciation Rights) | Disposition | 2014-07-30 | 62,500 | $0.00 | 62,500 | $29.92 |
Common Stock | Sars (Stock Appreciation Rights) | Disposition | 2014-07-30 | 62,500 | $0.00 | 62,500 | $26.69 |
Common Stock | Sars (Stock Appreciation Rights) | Disposition | 2014-07-30 | 62,500 | $0.00 | 62,500 | $16.46 |
Common Stock | Sars (Stock Appreciation Rights) | Disposition | 2014-07-30 | 40,000 | $0.00 | 40,000 | $21.19 |
Common Stock | Sars (Stock Appreciation Rights) | Disposition | 2014-07-30 | 62,500 | $0.00 | 62,500 | $19.26 |
Common Stock | Sars (Stock Appreciation Rights) | Disposition | 2014-07-30 | 62,500 | $0.00 | 62,500 | $27.63 |
Common Stock | Sars (Stock Appreciation Rights) | Disposition | 2014-07-30 | 62,500 | $0.00 | 62,500 | $26.09 |
Common Stock | Sars (Stock Appreciation Rights) | Disposition | 2014-07-30 | 62,500 | $0.00 | 62,500 | $32.93 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2020-06-01 | No | 4 | M | Direct | |
0 | 2021-06-01 | No | 4 | M | Direct | |
0 | 2022-06-01 | No | 4 | M | Direct | |
0 | 2023-06-01 | No | 4 | M | Direct | |
0 | 2024-06-01 | No | 4 | M | Direct | |
0 | 2016-05-16 | No | 4 | M | Direct | |
0 | 2017-05-17 | No | 4 | M | Direct | |
0 | 2018-06-01 | No | 4 | M | Direct | |
0 | 2019-06-01 | No | 4 | M | Direct | |
0 | 2019-10-30 | No | 4 | M | Direct | |
0 | 2020-06-01 | No | 4 | M | Direct | |
0 | 2021-06-01 | No | 4 | M | Direct | |
0 | 2022-06-01 | No | 4 | M | Direct | |
0 | 2023-06-01 | No | 4 | M | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.00 to $39.35. Full information regarding the number of shares sold at each separate price will be provided upon request of the commission staff, ConMed, or a ConMed security holder.
- Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan, with the RSUs generally vesting over a five year period with the first 20% of the RSU's vesting one year after the grant date.
- According to Section 2(d) of the Separation and Release Agreement dated July 22, 2014, and attached as Exhibit 10.1 of the Form 8-K dated July 23, 2014, all of Mr. Joseph Corasanti's unvested RSUs and SARs accelerated, other than the 2014 SARS which were cancelled.
- The stock appreciation rights ("SARs") were granted under the Issuer's 2006 Stock Incentive Plan and generally vest in equal amounts over a five year period.
- The stock appreciation rights ("SARs") were granted under the Company's 2006 Stock Incentive Plan and generally vest in equal amounts over a five year period.
- The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.
- The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a period with the first 20% tranche to vest on June 1, 2010 with each successive 20% tranche to vest on June 1 the following year.